Statement Of Financial Position [Abstract]

Biofrontera AG - Filing #6464128

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
2,934 EUR
3,290 EUR
Intangible assets other than goodwill
1,001 EUR
1,152 EUR
Investments accounted for using equity method
0 EUR
1,718 EUR
Investments in subsidiaries, joint ventures and associates reported in separate financial statements
420,000 EUR
0 EUR
Deferred tax assets
9,029 EUR
6,818 EUR
Cash and cash equivalents
3,124 EUR
3,080 EUR
Assets
29,654 EUR
30,732 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
6,077 EUR
63,807 EUR
Other reserves
120,390 EUR
180,789 EUR
Equity
137,497 EUR
18,856 EUR
124,739 EUR
6,077 EUR
22,000 EUR
18,857 EUR
63,807 EUR
1,000 EUR
19,980 EUR
181,158 EUR
137,330 EUR
20,336 EUR
180,789 EUR
63,807 EUR
0 EUR
137,318 EUR
Equity and liabilities
29,654 EUR
30,732 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.